Acta Vet. Brno 2010, 79: 41-49

https://doi.org/10.2754/avb201079010041

Effect of Newly Synthesized Compounds 44Bu and 444 on QRS-Complex Width and Fast Sodium Current: Differences between Isomers

Anna Kilianová1, Markéta Bébarová1, Klára Beránková2, Radka Opatřilová3, Michal Pásek1,4, Ladislava Bartošová2

1Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
2Department of Human Pharmacology and Toxicology
3Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
4Institute of Thermomechanics, Czech Academy of Sciences - branch Brno, Czech Republic

Received May 11, 2009
Accepted September 8, 2009

References

1. Agrawal YK, Bhatt HG, Raval HG, Oza PM, Gogo IPJ 2007: Chirality-a new era of therapeutics. Mini Rev Med Chem 7: 451-460 <https://doi.org/10.2174/138955707780619617>
2. Akita M, Kuwahara M, Tsubone H, Sugano S 1998: ECG changes during furosemide-induced hypokalemia in the rat. J Electrocardiol 31: 45-49 <https://doi.org/10.1016/S0022-0736(98)90006-1>
3. Barbier GH, Shettigar UR, Appunn DO 1995: Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol. Int J Clin Pharmacol Ther 33: 212-218
4. Bartosova L, Frydrych M, Vaculova G, Berankova K, Bebarova M, Opatrilova R, Strnadova V, Mokry P, Brunclik V, Kolevska J, Krcmar J, Bartosikova L, Florian T, Necas J 2006: Ultrashort bradycardic effect of newly synthesized compounds. Acta Vet Brno 75: 183-196 <https://doi.org/10.2754/avb200675020183>
5. Bartosova L, Novak F, Frydrych M, Opatrilova R, Brunclik V, Kolevska J, Mokry P, Kollar P, Bebarova M, Strnadova V, Necas J 2007: Antiarrhythmic effect of newly synthetized compound 44Bu on model of aconitine-induced arrhythmia – compared to lidocaine. Eur J Pharmacol 575: 127-133 <https://doi.org/10.1016/j.ejphar.2007.07.044>
6. Bartosova L, Berankova K, Souckova I, Parak T, Bebarova M, Frydrych M, Suchy P 2008: Aconitine- intoxication from the perspective of the occurrence of heart rhythm disorders and possibility of therapeutic intervention of a newly synthesized compound 44Bu. Toxicology Letters 180S: S229 <https://doi.org/10.1016/j.toxlet.2008.06.030>
7. Bébarová M, Matejovič P, Pásek M, Šimurdová M, Šimurda J 2005: Effect of ajmaline on action potential and ionic currents in rat ventricular myocytes. Gen Physiol Biophys 24: 311-325
8. Brisinda D, Caristo ME, Fenici R 2006: Contactless magnetocardiographic mapping in anesthetized Wistar rats: evidence of age-related changes of cardiac electrical activity. Am J Physiol Heart Circ Physiol 291: H368-H378 <https://doi.org/10.1152/ajpheart.01048.2005>
9. Callans DJ 2008: Apples and oranges: comparing antiarrhythmic drugs and catheter ablation for treatment of atrial fibrillation. Circulation 118: 2488-2490 <https://doi.org/10.1161/CIRCULATIONAHA.108.823179>
10. Carmeliet E, Mubagwa K 1998: Antiarrhythmic drugs and cardiac ion channels: mechanisms of action. Prog Biophys Mol Biol 70: 1-72 <https://doi.org/10.1016/S0079-6107(98)00002-9>
11. Eap CB, Crettol S, Rougier JS, Schläpfer J, Sintra Grilo L, Déglon JJ, Besson J, Croquette-Krokar M, Carrupt PA, Abriel H 2007: Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2D6 slow metabolizers. Clin Pharmacol Ther 81: 719-728 <https://doi.org/10.1038/sj.clpt.6100120>
12. Jamie H, Kilian G, Dyason K, Milne PJ 2002: The effect of the isomers of cyclo(Trp-Pro) on heart and ion-channel activity. J Pharm Pharmacol 54: 1659-1665 <https://doi.org/10.1211/002235702252>
13. Králová E, Mokrán T, Murín J, Stankovicová T 2008: Electrocardiography in two models of isoproterenol-induced left ventricular remodeling. Physiol Res 57 Suppl 2: S83-S89
14. Kulig K, Malawska B, Nowicki P 2004: Influence of the absolute configuration on pharmacological activity of antihypertensive and antiarythmic drugs. Pol J Pharmacol 56: 499–508
15. Liu H, Tateyama M, Clancy CE, Abriel H, Kass RS 2002: Channel openings are necessary but not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence from the analysis of disease-linked mutations. J Gen Physiol 120: 39-51 <https://doi.org/10.1085/jgp.20028558>
16. Maatz LF, Wood GJ, Rivero DH, Saldiva PH 2009: Tracheal instillation of urban PM(2.5) suspension promotes acute cardiac polarization changes in rats. Braz J Med Biol Res 42: 207-213 <https://doi.org/10.1590/S0100-879X2009000200009>
17. Magyar J, Rusznák Z, Harasztosi C, Körtvély A, Pacher P, Bányász T, Pankucsi C, Kovács L, Szûcs G, Nánási PP, Kecskeméti V 2003: Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues. Int J Mol Med 11: 535-542
18. Mokrý P, Csöllei J, Račanská E, Tumová I, Zemanová-Durmisová M 2001: Syntéza a studium potenciálních blokátorů beta-adrenergních receptorů s ultrakrátkým účinkem. 30th conference Synthesis and analysis of drugs, p. 87
19. Mokrý P, Zemanová M, Csöllei J, Račanská E, Tumová I 2003: Synthesis and pharmacological evaluation of novel potential ultrashort-acting β-blockers. Pharmazie 58: 18-21
20. Opatrilova R, Mokry P, Bartosova L 2005: Characteristics and attributes of new potential drug. Chem. Zi 1, 142
21. Quon CY, Mai K, Patil G, Stampfli HF 1988: Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Drug Metab Dispos 16: 425-428
22. Ranger S, Talajic M, Lemery R, Roy D, Villemaire C, Nattel S 1991: Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans. Circulation 83: 1987-1994 <https://doi.org/10.1161/01.CIR.83.6.1987>
23. Remme CA, Wilde AA, Bezzina CR 2008: Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc Med 18: 78-87 <https://doi.org/10.1016/j.tcm.2008.01.002>
24. Roden DM, Anderson ME 2006: Proarrhythmia. Handb Exp Pharmacol 171: 73-97 <https://doi.org/10.1007/3-540-29715-4_3>
25. Saitoh M, Sugiyama A, Nakazawa T, Hashimoto K 2002: Cardiovascular effects of orally administered HNS-32, an originally synthesized azulene-1-carboxamidine derivative, assessed in the in vivo rat model. Jpn J Pharmacol 89: 316-319 <https://doi.org/10.1254/jjp.89.316>
26. Sakai R, Inoue D, Ishibashi K, Inoue M, Shirayama T, Yamahara Y, Asayama J, Nakagawa M 1995: Kinetics of frequency-dependent conduction delay by class I antiarrhythmic drugs in human atrium. J Cardiovasc Pharmacol 25: 953-960 <https://doi.org/10.1097/00005344-199506000-00014>
27. Shimizu W, Antzelevitch C, Suyama K, Kurita T, Taguchi A, Aihara N, Takaki H, Sunagawa K, Kamakura S 2000: Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 11: 1320-1329 <https://doi.org/10.1046/j.1540-8167.2000.01320.x>
28. Shinozaki T, Satoh S, Miura M, Iwabuchi K, Takeuchi M, Suzuki S, Baba S, Katoh H, Funakoshi M, Keitoku M, Watanabe J, Ishide N, Shirato K 1997: The rise time of the monophasic action potential--a new index of local use-dependent conductivity by sodium channel blockers in human myocardium. Jpn Circ J 61: 979-987 <https://doi.org/10.1253/jcj.61.979>
29. Singh S, Murawski MM 2007: Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs. J Cardiovasc Pharmacol Ther 12: 175-180 <https://doi.org/10.1177/1074248407305608>
30. Stoschitzky K, Koshucharova G, Lercher P, Maier R, Sakotnik A, Klein W, Liebmann PM, Lindner W 2001: Stereoselective effects of (R)- and (S)-carvedilol in humans. Chirality 13: 342-346 <https://doi.org/10.1002/chir.1042>
31. Šimurdová M, Nováková Z, Nováková M, Šumbera J, Christé G, Šimurda J 1997: Kinetics of propafenone-induced block of sodium current in rat ventricular myocytes. Scripta medica 70: 263-275
32. Valenzuela C, Snyders DJ, Bennett PB, Tamargo J, Hondeghem LM 1995: Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation 92: 3014-3024 <https://doi.org/10.1161/01.CIR.92.10.3014>
33. Wang RX, Jiang WP, Li XR, Lai LH 2008: Effects of (S)-amlodipine and (R)-amlodipine on L-type calcium channel current of rat ventricular myocytes and cytosolic calcium of aortic smooth muscle cells. Pharmazie 63: 470-474
34. Xiao YF, Ke Q, Wang SY, Yang Y, Chen Y, Wang GK, Morgan JP, Cox B, Leaf A 2004: Electrophysiologic properties of lidocaine, cocaine, and n-3 fatty-acids block of cardiac Na+ channels. Eur J Pharmacol 485: 31-41 <https://doi.org/10.1016/j.ejphar.2003.11.042>
35. Yoshida Y, Terajima K, Sato C, Akada S, Miyagi Y, Hongo T, Takeda S, Tanaka K, Sakamoto A 2008: Clinical role and efficacy of landiolol in the intensive care unit. J Anesth 22: 64-69 <https://doi.org/10.1007/s00540-007-0573-3>
front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Archive